Cancer Hospital of Shantou University Medical College
Shantou, Guangdong, China
Cancer treatment center in Shantou
7 Raoping Rd, Jinping District, Shantou, Guangdong Province, 515031
About Cancer Hospital of Shantou University Medical College
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
BeiGene
9
Hoffmann-La Roche
7
Chuangzhen Chen
5
Shanghai Junshi Bioscience Co., Ltd.
2
Akeso
1
Betta Pharmaceuticals Co., Ltd.
1
Biotech Pharmaceutical Co., Ltd.
1
Daiichi Sankyo, Inc.
1
EMD Serono Research & Development Institute, Inc.
1
Fengxi Su
1
Five Prime Therapeutics, Inc.
1
Clinical Trials at Cancer Hospital of Shantou University Medical College
During the past decade, Cancer Hospital of Shantou University Medical College conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 3 clinical trials were completed, i.e. on
average, 8.8% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population
2009-12-01
2015-06-01
Terminated
285
Aromasin® Interventional Study Of Early Invasive Breast Cancer Patients In China
2011-02-09
2018-11-30
Completed
564
Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer
2007-06-01
2019-12-01
Unknown status
430
A Study of Bevacizumab Versus Placebo in Combination With Carboplatin/Paclitaxel in Participants With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Previous Chemotherapy
2011-05-23
2017-08-17
Completed
276
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
2012-08-01
2015-08-01
Completed
85
A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma
2015-03-01
2021-12-01
Unknown status
200
Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer
2015-08-01
2022-08-01
Recruiting
202
Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma
2015-11-01
2019-06-01
Unknown status
504
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Cancer Hospital of Shantou University Medical College" #1 sponsor was "BeiGene" with 9 trials, followed by "Hoffmann-La Roche" with 7 trials
sponsored, "Chuangzhen Chen" with 5 trials sponsored, "Shanghai Junshi Bioscience Co., Ltd." with 2 trials sponsored and "Akeso"
with 2 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Hospital of Shantou University Medical College"
#1 collaborator was "Affiliated Cancer Hospital of Shantou University Medical College" with 1 trials as a collaborator, "Fudan University" with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Shanghai Chest Hospital" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were
collaborators in the rest 11 trials.
Clinical Trials Conditions at Cancer Hospital of Shantou University Medical College
According to Clinical.Site data, the most researched conditions in "Cancer Hospital of Shantou University Medical College" are
"Non-Small Cell Lung Cancer" (5 trials), "Cervical Cancer" (3 trials), "Esophageal Squamous Cell Carcinoma" (3 trials), "Breast Cancer" (2 trials) and "Breast Neoplasms" (2 trials). Many other conditions were trialed in "Cancer Hospital of Shantou University Medical College" in a lesser frequency.
Clinical Trials Intervention Types at Cancer Hospital of Shantou University Medical College
Most popular intervention types in "Cancer Hospital of Shantou University Medical College" are "Drug" (32 trials), "Biological" (4 trials), "Radiation" (4 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (6 trials), "Atezolizumab" (5 trials), "Cisplatin" (5 trials) and "Tislelizumab" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Cancer Hospital of Shantou University Medical College
The vast majority of trials in "Cancer Hospital of Shantou University Medical College" are
36 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Cancer Hospital of Shantou University Medical College
Currently, there are 29 active trials in "Cancer Hospital of Shantou University Medical College".
2 are not yet recruiting,
15 are recruiting,
11 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 5 completed trials in Cancer Hospital of Shantou University Medical College,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Hospital of Shantou University Medical College, 1 "Phase 1"
clinical trials were conducted, 8 "Phase 2" clinical
trials and 28 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".